| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029148 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 02/12/2004 | US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029124 Generation hybrid Dna using primers and ligase; analyzing gene expression patterns |
| 02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
| 02/12/2004 | US20040029107 DNA sequence coding for bacteriophage recombinase; ligand-binding domain of steroid receptors; vectors |
| 02/12/2004 | US20040029106 Duplexed parvovirus vectors |
| 02/12/2004 | US20040028692 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/12/2004 | US20040028685 EphA2 monoclonal antibodies and methods of use thereof |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028677 Chimeric allograft tolerance induction, monitoring and maintenance |
| 02/12/2004 | US20040028673 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
| 02/12/2004 | US20040028669 Human gene critical to fertility |
| 02/12/2004 | US20040028663 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
| 02/12/2004 | US20040028662 Method for producing a recipient-specific tissue transplant or tissue implant |
| 02/12/2004 | US20040028661 Expansion of cells using thrombopoietin and anti-transforming growth factor-beta |
| 02/12/2004 | US20040028660 Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028657 Cells laminated to substrate; multilayer; wound healing agents |
| 02/12/2004 | US20040028656 Survival of neurons |
| 02/12/2004 | US20040028653 Self-rearranging DNA vectors |
| 02/12/2004 | US20040028649 Regenerating cells |
| 02/12/2004 | DE20315960U1 Knorpelersatzimplantat Cartilage replacement implant |
| 02/12/2004 | DE10251709A1 Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 und kosmetische oder pharmazeutische Zusammensetzungen, die solche Wirkstoffe enthalten Agents for stimulating the human beta-defensins type 2 and / or Type 3 and cosmetic or pharmaceutical compositions containing such active |
| 02/12/2004 | DE10234508A1 Immortalisierte Dickdarmepithelzellen und ihre Verwendung Immortalized colonic epithelial cells and their use |
| 02/12/2004 | DE10234200A1 Use of regulatory CD25 positive T cells for modulating inflammatory responses, for treating transplant rejection, autoimmune diseases and tumors |
| 02/12/2004 | CA2532376A1 Low pressure sperm cell separation system |
| 02/12/2004 | CA2523011A1 Clubroot resistant brassica oleracea plants |
| 02/12/2004 | CA2494868A1 Allele-specific sirna-mediated gene silencing |
| 02/12/2004 | CA2494859A1 Sirna-mediated gene silencing with viral vectors |
| 02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | CA2494316A1 Improved injection system |
| 02/12/2004 | CA2494240A1 Maxs as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493752A1 Papsss as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493745A1 Method and device for protein delivery into cells |
| 02/12/2004 | CA2493532A1 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 02/11/2004 | EP1388544A1 Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
| 02/11/2004 | EP1388327A1 Artificial kidney having function of metabolizing protein and mehtod of constructing the same |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387891A2 Compounds and methods for inhibiting axillary malodour |
| 02/11/2004 | EP1387890A2 Peptidylarginine deiminase 6 |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387885A1 Tridimensional biocompatible support structure for bioartificial organs and uses thereof |
| 02/11/2004 | EP1387884A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 02/11/2004 | EP1387855A2 Codon-optimised nucleic acid coding for apoaequorin and uses thereof |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/11/2004 | EP1387852A2 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor |
| 02/11/2004 | EP1387706A1 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications |
| 02/11/2004 | EP1387670A2 Immune modulation device for use in animals |
| 02/11/2004 | EP1104492B1 Subtle mitochondrial mutations as tumor markers |
| 02/11/2004 | EP0970377B1 Diagnosis of epithelial cell abnormalities |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 02/11/2004 | EP0804482B1 Cytokines that bind the cell surface receptor hek |
| 02/11/2004 | CN1474872A Method for modifying plant morphology, biochemistry and physiology |
| 02/11/2004 | CN1474871A Inhibitor proteins |
| 02/11/2004 | CN1474869A Novel compounds |
| 02/11/2004 | CN1474831A Membrane scaffold proteins |
| 02/11/2004 | CN1473936A Effectively producing transgene plant using auxin precursor |
| 02/11/2004 | CN1473930A High metastasis human breast cancer cell system and its establishing method |
| 02/11/2004 | CN1473929A Method and formula for dissolving cell-loading micro capsule under physiological condition |
| 02/11/2004 | CN1473928A Method for removing oocyte nucleus |
| 02/11/2004 | CN1473854A Recombined IL4 antibody for treating IL4 insertion diseases |
| 02/11/2004 | CN1473551A Artificial tissue engineeing biological cornea |
| 02/11/2004 | CN1137994C Polypeptide having glucanotransferase activity and nucleic acids encoding same |
| 02/11/2004 | CN1137992C Cultivating method for increasing sweet wormwood organ biomass and artemisine content |
| 02/11/2004 | CN1137896C Vaccine for hoof-and-mouth disease and preparing method thereof |
| 02/10/2004 | US6689940 Nucleic acid encoding the arabidopsis ELF3 protein and a method of using it to alter photoperiod in plants |
| 02/10/2004 | US6689937 Transgenic mouse model of basal cell carcinoma |
| 02/10/2004 | US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same |
| 02/10/2004 | US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity |
| 02/10/2004 | US6689758 Treating wounds; using an early growth response-1 transcription factor polypeptide or fragment |
| 02/10/2004 | US6689611 Modified Streptomyces host cells for increased avermectin production and methods of making the same |
| 02/10/2004 | US6689608 Polymeric matrix formed of biodegradable, biocompatible, synthetic, amorphous or semi-crystalline polymer having specified crystallinity, porosity and pore size, suitable for attachment and proliferation of dissociated cells |
| 02/10/2004 | US6689607 Antibody for use in the treatment of aberrant cell proliferation and differentiation defects |
| 02/10/2004 | US6689604 Lipopolysaccharide α-2,3 sialyltransferase of Campylobacter jejuni and its uses |
| 02/10/2004 | US6689598 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/10/2004 | US6689597 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 02/10/2004 | US6689594 Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device |
| 02/10/2004 | US6689593 Generation of farnesol; culture genetically engineered microorganism in nutrient broth, ferment in nutrient broth and recover farnesol |
| 02/10/2004 | US6689585 GABA-B2 receptor |
| 02/10/2004 | US6689583 Chromatin regulator genes |
| 02/10/2004 | US6689580 Growth factor |
| 02/10/2004 | US6689570 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 02/10/2004 | US6689562 Mammalian IAP gene family, primers, probes and detection methods |
| 02/10/2004 | US6689558 Detecting modulators of gene expression; incubate preferential cells with modulators, determine adjustment in gene expression |
| 02/10/2004 | US6689398 Triterpene compositions and methods for use thereof |
| 02/10/2004 | US6689369 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/10/2004 | US6689365 Follicle stimulating hormone, luteinizing hormone; varying ratios of lh activity as compared to fsh activity; fsh beta is linked through a linker to lh beta; the alpha subunit is downstream from both; fusion protein |
| 02/09/2004 | CA2842992A1 Production of thin, irregular chips with scalloped edges and surface bubbles |
| 02/09/2004 | CA2421269A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/08/2004 | CA2436691A1 Preparation, characterization and quantification of active fractions that promote cell growth and recombinant-protein expression |
| 02/05/2004 | WO2004011941A1 Methods and reagents for improved selection of biological materials |
| 02/05/2004 | WO2004011673A1 Auto-stimulating cells and method for making and using the same |
| 02/05/2004 | WO2004011667A2 Geranyl diphosphate synthase molecules, and nucleic acid molecules encoding same |
| 02/05/2004 | WO2004011656A1 Method for enhancing yield of recombinant protein production from plants |
| 02/05/2004 | WO2004011651A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |